BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA. Mediterr J Hematol Infect Dis 2022, 15 (1), e2023001. https://doi.org/10.4084/MJHID.2023.001.